174 related articles for article (PubMed ID: 37595583)
1. Spatiotemporal cell junction assembly in human iPSC-CM models of arrhythmogenic cardiomyopathy.
Kim SL; Trembley MA; Lee KY; Choi S; MacQueen LA; Zimmerman JF; de Wit LHC; Shani K; Henze DE; Drennan DJ; Saifee SA; Loh LJ; Liu X; Parker KK; Pu WT
Stem Cell Reports; 2023 Sep; 18(9):1811-1826. PubMed ID: 37595583
[TBL] [Abstract][Full Text] [Related]
2. Sodium current abnormalities and deregulation of Wnt/β-catenin signaling in iPSC-derived cardiomyocytes generated from patient with arrhythmogenic cardiomyopathy harboring compound genetic variants in plakophilin 2 gene.
Khudiakov A; Zaytseva A; Perepelina K; Smolina N; Pervunina T; Vasichkina E; Karpushev A; Tomilin A; Malashicheva A; Kostareva A
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165915. PubMed ID: 32768677
[TBL] [Abstract][Full Text] [Related]
3. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
4. Modeling reduced contractility and impaired desmosome assembly due to plakophilin-2 deficiency using isogenic iPS cell-derived cardiomyocytes.
Inoue H; Nakamura S; Higo S; Shiba M; Kohama Y; Kondo T; Kameda S; Tabata T; Okuno S; Ikeda Y; Li J; Liu L; Yamazaki S; Takeda M; Ito E; Takashima S; Miyagawa S; Sawa Y; Hikoso S; Sakata Y
Stem Cell Reports; 2022 Feb; 17(2):337-351. PubMed ID: 35063130
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmogenic cardiomyopathy: An in-depth look at molecular mechanisms and clinical correlates.
Costa S; Cerrone M; Saguner AM; Brunckhorst C; Delmar M; Duru F
Trends Cardiovasc Med; 2021 Oct; 31(7):395-402. PubMed ID: 32738304
[TBL] [Abstract][Full Text] [Related]
6. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.
Camors EM; Roth AH; Alef JR; Sullivan RD; Johnson JN; Purevjav E; Towbin JA
Circulation; 2022 May; 145(21):1609-1624. PubMed ID: 35437032
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).
Janz A; Zink M; Cirnu A; Hartleb A; Albrecht C; Rost S; Klopocki E; Günther K; Edenhofer F; Ergün S; Gerull B
Stem Cell Res; 2021 May; 53():102256. PubMed ID: 33640690
[TBL] [Abstract][Full Text] [Related]
8. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy.
Tsui H; van Kampen SJ; Han SJ; Meraviglia V; van Ham WB; Casini S; van der Kraak P; Vink A; Yin X; Mayr M; Bossu A; Marchal GA; Monshouwer-Kloots J; Eding J; Versteeg D; de Ruiter H; Bezstarosti K; Groeneweg J; Klaasen SJ; van Laake LW; Demmers JAA; Kops GJPL; Mummery CL; van Veen TAB; Remme CA; Bellin M; van Rooij E
Sci Transl Med; 2023 Mar; 15(688):eadd4248. PubMed ID: 36947592
[TBL] [Abstract][Full Text] [Related]
9. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
10. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.
Jahng JWS; Black KE; Liu L; Bae HR; Perez M; Ashley EA; Sallam K; Wu JC
Stem Cell Res; 2021 May; 53():102284. PubMed ID: 33743362
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Ca
Kim JC; Pérez-Hernández M; Alvarado FJ; Maurya SR; Montnach J; Yin Y; Zhang M; Lin X; Vasquez C; Heguy A; Liang FX; Woo SH; Morley GE; Rothenberg E; Lundby A; Valdivia HH; Cerrone M; Delmar M
Circulation; 2019 Sep; 140(12):1015-1030. PubMed ID: 31315456
[TBL] [Abstract][Full Text] [Related]
12. Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.
Caspi O; Huber I; Gepstein A; Arbel G; Maizels L; Boulos M; Gepstein L
Circ Cardiovasc Genet; 2013 Dec; 6(6):557-68. PubMed ID: 24200905
[TBL] [Abstract][Full Text] [Related]
13. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Characterization of a Human In Vitro Model of Arrhythmogenic Cardiomyopathy Under Topological and Mechanical Stimuli.
Martewicz S; Luni C; Serena E; Pavan P; Chen HV; Rampazzo A; Elvassore N
Ann Biomed Eng; 2019 Mar; 47(3):852-865. PubMed ID: 30569242
[TBL] [Abstract][Full Text] [Related]
15. Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.
Ermon B; Volpato CB; Cattelan G; Silipigni R; Di Segni M; Cantaloni C; Casella M; Pramstaller PP; Pompilio G; Sommariva E; Meraviglia V; Rossini A
Stem Cell Res; 2018 Oct; 32():78-82. PubMed ID: 30219716
[TBL] [Abstract][Full Text] [Related]
16. Loss of Nuclear Envelope Integrity and Increased Oxidant Production Cause DNA Damage in Adult Hearts Deficient in PKP2: A Molecular Substrate of ARVC.
Pérez-Hernández M; van Opbergen CJM; Bagwan N; Vissing CR; Marrón-Liñares GM; Zhang M; Torres Vega E; Sorrentino A; Drici L; Sulek K; Zhai R; Hansen FB; Christensen AH; Boesgaard S; Gustafsson F; Rossing K; Small EM; Davies MJ; Rothenberg E; Sato PY; Cerrone M; Jensen THL; Qvortrup K; Bundgaard H; Delmar M; Lundby A
Circulation; 2022 Sep; 146(11):851-867. PubMed ID: 35959657
[TBL] [Abstract][Full Text] [Related]
17. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype.
Cerrone M; Lin X; Zhang M; Agullo-Pascual E; Pfenniger A; Chkourko Gusky H; Novelli V; Kim C; Tirasawadichai T; Judge DP; Rothenberg E; Chen HS; Napolitano C; Priori SG; Delmar M
Circulation; 2014 Mar; 129(10):1092-103. PubMed ID: 24352520
[TBL] [Abstract][Full Text] [Related]
18.
Lyon A; van Opbergen CJM; Delmar M; Heijman J; van Veen TAB
Front Physiol; 2021; 12():732573. PubMed ID: 34630150
[No Abstract] [Full Text] [Related]
19. Recessive variants in plakophilin-2 contributes to early-onset arrhythmogenic cardiomyopathy with severe heart failure.
Chen K; Rao M; Guo G; Duru F; Chen L; Chen X; Song J; Hu S
Europace; 2019 Jun; 21(6):970-977. PubMed ID: 30830208
[TBL] [Abstract][Full Text] [Related]
20. Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm.
Cerrone M; Montnach J; Lin X; Zhao YT; Zhang M; Agullo-Pascual E; Leo-Macias A; Alvarado FJ; Dolgalev I; Karathanos TV; Malkani K; Van Opbergen CJM; van Bavel JJA; Yang HQ; Vasquez C; Tester D; Fowler S; Liang F; Rothenberg E; Heguy A; Morley GE; Coetzee WA; Trayanova NA; Ackerman MJ; van Veen TAB; Valdivia HH; Delmar M
Nat Commun; 2017 Jul; 8(1):106. PubMed ID: 28740174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]